Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hyperimmunoglobulinemia and rate of HIV type 1 infection progression.

Literature DB >> 15000704

Hyperimmunoglobulinemia and rate of HIV type 1 infection progression.

Arthur Abelian¹, Keith Burling, Philippa Easterbrook, Greg Winter.

Abstract

Entities: Disease

Mesh：

Substances：
Immunoglobulins

Year: 2004 PMID： 15000704 DOI： 10.1089/088922204322749576

Source DB: PubMed Journal: AIDS Res Hum Retroviruses ISSN： 0889-2229 Impact factor: 2.205

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. Pseudohyponatremia in a patient with HIV and hepatitis C coinfection.

Authors: Brian T Garibaldi; Scott J Cameron; Michael Choi
Journal: J Gen Intern Med Date: 2007-11-10 Impact factor: 5.128

2. Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.

Authors: Clarisa M Buckner; Susan Moir; Jason Ho; Wei Wang; Jacqueline G Posada; Lela Kardava; Emily K Funk; Amy K Nelson; Yuxing Li; Tae-Wook Chun; Anthony S Fauci
Journal: J Virol Date: 2013-03-13 Impact factor: 5.103

3. Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.

Authors: Judith Dalmau; Maria Carmen Puertas; Marta Azuara; Ana Mariño; Nicole Frahm; Beatriz Mothe; Nuria Izquierdo-Useros; Maria José Buzón; Roger Paredes; Lourdes Matas; Todd M Allen; Christian Brander; Carlos Rodrigo; Bonaventura Clotet; Javier Martinez-Picado
Journal: Clin Infect Dis Date: 2009-01-15 Impact factor: 9.079

Hyperimmunoglobulinemia and rate of HIV type 1 infection progression.

1. Pseudohyponatremia in a patient with HIV and hepatitis C coinfection.

2. Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.

3. Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.

4. Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS.

5. Early identification of seronegative human immunodeficiency virus type 1 infection with severe presentation.

6. High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challenge.